Insider · CIK 0001851034
John David Finley
ceocfoofficerdirector
Files at PALI (PALISADE BIO, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | PALI PALISADE BIO, INC. | MOption exercise Common Stock | +3,227,384 | - | - | 3,356,672 | 5 d ago |
| Oct 6, 2026 | PALI PALISADE BIO, INC. | FTax withholding Common Stock | -1,411,982 | $1.49 | $2.1M | 1,944,690 | 5 d ago |
| Oct 6, 2026 | PALI PALISADE BIO, INC. | MOption exercise Restricted Stock Unitsderivative | -3,059,800 | $0.00 | $0 | 6,119,600 | 5 d ago |
| Oct 6, 2026 | PALI PALISADE BIO, INC. | MOption exercise Restricted Stock Unitsderivative | -167,584 | $0.00 | $0 | 1,508,249 | 5 d ago |
| Sep 4, 2025 | PALI PALISADE BIO, INC. | AGrant or award Phantom Unitsderivative | +323,400 | $0.00 | $0 | 323,400 | Sep 5, 2025 |
| Feb 11, 2025 | PALI PALISADE BIO, INC. | AGrant or award Stock Option (Right to Buy)derivative | +47,000 | $0.00 | $0 | 47,000 | Feb 13, 2025 |
| Feb 11, 2025 | PALI PALISADE BIO, INC. | AGrant or award Restricted Stock Unitsderivative | +40,000 | $0.00 | $0 | 40,000 | Feb 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.